Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Álvaro Tejerizo-García, Jesús S Jiménez-López, José L Muñoz-González, Sara Bartolomé-Sotillos, Laura Marqueta-Marqués, Gregorio López-González & José F Pérez-Regadera Gómez. (2013) Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients. OncoTargets and Therapy 6, pages 1305-1313.
Read now
Read now
Andrea J O’Hara & Daphne W Bell. (2012) The genomics and genetics of endometrial cancer. Advances in Genomics and Genetics 2, pages 33-47.
Read now
Read now
Articles from other publishers (39)
Panagiotis A. Konstantinopoulos, Elizabeth K. Lee, Niya Xiong, Carolyn Krasner, Susana Campos, David L. Kolin, Joyce F. Liu, Neil Horowitz, Alexi A. Wright, Sara Bouberhan, Richard T. Penson, Oladapo Yeku, Brittany Bowes, Hope Needham, Martin Hayes, Hannah Sawyer, Madeline Polak, Meghan Shea, Su-Chun Cheng, Cesar Castro & Ursula A. Matulonis. (2023) A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor–Positive Recurrent Endometrial Cancer. Journal of Clinical Oncology 41:3, pages 599-608.
Crossref
Crossref
Hye-Yeon Ju, Jung Yoon Ho, Jun Kang, Soo Young Hur, Sejin Kim, Youn Jin Choi & Mi-Ryung Han. (2022) Whole-Exome Sequencing Reveals Clinical Potential of Circulating Tumor DNA from Peritoneal Fluid and Plasma in Endometrial Cancer. Cancers 14:10, pages 2506.
Crossref
Crossref
Angelika Buczyńska, Iwona Sidorkiewicz, Adam Jacek Krętowski, Monika Zbucka-Krętowska & Agnieszka Adamska. (2022) Metformin Intervention—A Panacea for Cancer Treatment?. Cancers 14:5, pages 1336.
Crossref
Crossref
Susana M. Campos, Suzanne Berlin, Carolyn N. Krasner, Christin Whalen, Tina Atkinson, Kristin Meegan, Lauren Pereira, Karin Tyburski, Weixiu Lou, Hang Lee, Neil Horowitz & Richard T. Penson. (2022) A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies. Cancer Chemotherapy and Pharmacology 89:3, pages 423-430.
Crossref
Crossref
Pamela T. Soliman & Karen H. Lu. 2022. Comprehensive Gynecology. Comprehensive Gynecology
691
706.e5
.
Regina Esi Mensimah Baiden-Amissah, Daniela Annibali, Sandra Tuyaerts & Frederic Amant. (2021) Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?. Cancers 13:16, pages 3988.
Crossref
Crossref
Lysandra Castro, Jingli Liu, Linda Yu, Alanna D Burwell, Trey O Saddler, Lindsay A Santiago, William Xue, Julie F Foley, Michael Staup, Norris D Flagler, Min Shi, Linda S Birnbaum & Darlene Dixon. (2021) Differential receptor tyrosine kinase phosphorylation in the uterus of rats following developmental exposure to tetrabromobisphenol A. Toxicology Research and Application 5, pages 239784732110471.
Crossref
Crossref
Ketevani Kankava, Eka Kvaratskhelia & Elene Abzianidze. 2021. Overcoming Drug Resistance in Gynecologic Cancers. Overcoming Drug Resistance in Gynecologic Cancers
169
193
.
Arkadiusz Z. Dudek, Kate Baxstrom, Sushma Bharadwaj, Anne Blaes, Amit Kulkarni, Emil Lou, Vijeyaluxmy Nehru, Emma Rabinovich, Ardaman Shergill & Maya Viner. 2020. Precision Medicine in Oncology. Precision Medicine in Oncology
1
60
.
Maria Alba Sorolla, Eva Parisi & Anabel Sorolla. (2020) Determinants of Sensitivity to Radiotherapy in Endometrial Cancer. Cancers 12:7, pages 1906.
Crossref
Crossref
Shih-Chun Cheng, Kueian Chen, Chih-Yung Chiu, Kuan-Ying Lu, Hsin-Ying Lu, Meng-Han Chiang, Cheng-Kun Tsai, Chi-Jen Lo, Mei-Ling Cheng, Ting-Chang Chang & Gigin Lin. (2019) Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy. Metabolomics 15:11.
Crossref
Crossref
Federica Torricelli, Davide Nicoli, Riccardo Bellazzi, Alessia Ciarrocchi, Enrico Farnetti, Valentina Mastrofilippo, Raffaella Zamponi, Giovanni Battista La Sala, Bruno Casali & Vincenzo Dario Mandato. (2018) Computational development of a molecular-based approach to improve risk stratification of endometrial cancer patients. Oncotarget 9:39, pages 25517-25528.
Crossref
Crossref
Jodie N. Painter, Tracy A. O'Mara, Andrew P. Morris, Timothy H. T. Cheng, Maggie Gorman, Lynn Martin, Shirley Hodson, Angela Jones, Nicholas G. Martin, Scott Gordon, Anjali K. Henders, John Attia, Mark McEvoy, Elizabeth G. Holliday, Rodney J. Scott, Penelope M. Webb, Peter A. Fasching, Matthias W. Beckmann, Arif B. Ekici, Alexander Hein, Matthias Rübner, Per Hall, Kamila Czene, Thilo Dörk, Matthias Dürst, Peter Hillemanns, Ingo Runnebaum, Diether Lambrechts, Frederic Amant, Daniela Annibali, Jeroen Depreeuw, Adriaan Vanderstichele, Ellen L. Goode, Julie M. Cunningham, Sean C. Dowdy, Stacey J. Winham, Jone Trovik, Erling Hoivik, Henrica M. J. Werner, Camilla Krakstad, Katie Ashton, Geoffrey Otton, Tony Proietto, Emma Tham, Miriam Mints, Shahana Ahmed, Catherine S. Healey, Mitul Shah, Paul D. P. Pharoah, Alison M. Dunning, Joe Dennis, Manjeet K. Bolla, Kyriaki Michailidou, Qin Wang, Jonathan P. Tyrer, John L. Hopper, Julian Peto, Anthony J. Swerdlow, Barbara Burwinkel, Hermann Brenner, Alfons Meindl, Hiltrud Brauch, Annika Lindblom, Jenny Chang‐Claude, Fergus J. Couch, Graham G. Giles, Vessela N. Kristensen, Angela Cox, Krina T. Zondervan, Dale R. Nyholt, Stuart MacGregor, Grant W. Montgomery, Ian Tomlinson, Douglas F. Easton, Deborah J. Thompson & Amanda B. Spurdle. (2018) Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses. Cancer Medicine 7:5, pages 1978-1987.
Crossref
Crossref
Di Du, Wencai Ma, Melinda S. Yates, Tao Chen, Karen H. Lu, Yiling Lu, John N. Weinstein, Russell R. Broaddus, Gordon B. Mills & Yuexin Liu. (2018) Predicting high-risk endometrioid carcinomas using proteins. Oncotarget 9:28, pages 19704-19715.
Crossref
Crossref
Yannick Audet-Delage, Jean Grégoire, Patrick Caron, Véronique Turcotte, Marie Plante, Pierre Ayotte, David Simonyan, Lyne Villeneuve & Chantal Guillemette. (2018) Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery. The Journal of Steroid Biochemistry and Molecular Biology 178, pages 45-54.
Crossref
Crossref
Yannick Audet-Delage, Lyne Villeneuve, Jean Grégoire, Marie Plante & Chantal Guillemette. (2018) Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women. Frontiers in Endocrinology 9.
Crossref
Crossref
Pengming Sun, Lifang Xue, Yiyi Song, Xiaodan Mao, Lili Chen, Binhua Dong, Elena Loana Braicu & Jalid Sehouli. (2018) Regulation of matriptase and HAI-1 system, a novel therapeutic target in human endometrial cancer cells. Oncotarget 9:16, pages 12682-12694.
Crossref
Crossref
Peng Yu, Shengjie Li, Zhifei Zhang, Xiaolong Wen, Wei Quan, Qilong Tian, Chuang Gao, Wanqiang Su, Jianning Zhang & Rongcai Jiang. (2017) Progesterone-mediated angiogenic activity of endothelial progenitor cell and angiogenesis in traumatic brain injury rats were antagonized by progesterone receptor antagonist. Cell Proliferation 50:5, pages e12362.
Crossref
Crossref
Liming Guan & Gang Xu. (2017) Destructive effect of HIFU on rabbit embedded endometrial carcinoma tissues and their vascularities. Oncotarget 8:12, pages 19577-19591.
Crossref
Crossref
Takaya Shiozaki & Shannon N. Westin. 2017. Precision Molecular Pathology of Uterine Cancer. Precision Molecular Pathology of Uterine Cancer
187
223
.
Salvatore Giovanni Vitale, Gaetano Valenti, Ferdinando Antonio Gulino, Pietro Cignini & Antonio Biondi. (2016) Surgical treatment of high stage endometrial cancer: current perspectives. Updates in Surgery 68:2, pages 149-154.
Crossref
Crossref
Henry Sung-Ching Wong, Yung-Shun Juan, Mei-Shin Wu, Yan-Feng Zhang, Yu-Wen Hsu, Huang-Hui Chen, Wei-Min Liu & Wei-Chiao Chang. (2015) Integrative bioinformatic analyses of an oncogenomic profile reveal the biology of endometrial cancer and guide drug discovery. Oncotarget 7:5, pages 5909-5923.
Crossref
Crossref
Tatiana N. Buhtoiarova, Carol A. Brenner & Meenakshi Singh. (2016) Endometrial Carcinoma. American Journal of Clinical Pathology 145:1, pages 8-21.
Crossref
Crossref
P.R. Manna, D. Molehin & A.U. Ahmed. 2016. Molecular and Cellular Changes in the Cancer Cell. Molecular and Cellular Changes in the Cancer Cell
487
537
.
Ciro Comparetto & Franco Borruto. (2015) Molecular Technologies in Gynecologic Oncology. Journal of Cancer Research Updates 4:4.
Crossref
Crossref
Yun-Duo Liu, Meng Dai, Shan-Shan Yang, Min Xiao, Fan-Ling Meng & Xiu-Wei Chen. (2015) Overexpression of Lysine-Specific Demethylase 1 Is Associated With Tumor Progression and Unfavorable Prognosis in Chinese Patients With Endometrioid Endometrial Adenocarcinoma. International Journal of Gynecological Cancer 25:8, pages 1453-1460.
Crossref
Crossref
Arun Warrier. 2015. Uterine Cancer. Uterine Cancer
321
327
.
Ruijin Shao, Xin Li, Yi Feng, Jin-Fang Lin & Håkan Billig. (2014) Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma. Journal of Experimental & Clinical Cancer Research 33:1.
Crossref
Crossref
Daliah Tsoref, Stephen Welch, Susie Lau, James Biagi, Katia Tonkin, Lee Ann Martin, Susan Ellard, Prafull Ghatage, Laurie Elit, Helen J. Mackay, Ghassan Allo, Ming-Sound Tsao, Suzanne Kamel-Reid, Elizabeth A. Eisenhauer & Amit M. Oza. (2014) Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer. Gynecologic Oncology 135:2, pages 184-189.
Crossref
Crossref
Chang Ohk Sung & Insuk Sohn. (2014) The expression pattern of 19 genes predicts the histology of endometrial carcinoma. Scientific Reports 4:1.
Crossref
Crossref
Erica Stringer-Reasor, Gini Fleming, Daliah Tsoref & Amit Oza. 2014. Controversies in the Management of Gynecological Cancers. Controversies in the Management of Gynecological Cancers
59
68
.
Shermaine Mitchell-Ryan, Yiqiang Wang, Sudhir Raghavan, Manasa Punaha Ravindra, Eric Hales, Steven Orr, Christina Cherian, Zhanjun Hou, Larry H. Matherly & Aleem Gangjee. (2013)
Discovery of 5-Substituted Pyrrolo[2,3-
d
]pyrimidine Antifolates as Dual-Acting Inhibitors of Glycinamide Ribonucleotide Formyltransferase and 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase in De Novo Purine Nucleotide Biosynthesis: Implications of Inhibiting 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase to AMPK Activation and Antitumor Activity
. Journal of Medicinal Chemistry 56:24, pages 10016-10032.
Crossref
Crossref
Andrew J Clifford, Gonzalo Rincon, Janel E Owens, Juan F Medrano, Alanna J Moshfegh, David J Baer & Janet A Novotny. (2013) Single nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adults. Lipids in Health and Disease 12:1.
Crossref
Crossref
Natalia Buza, Diana P English, Alessandro D Santin & Pei Hui. (2013) Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice. Modern Pathology 26:12, pages 1605-1612.
Crossref
Crossref
Natalia Buza & Pei Hui. (2013)
Marked heterogeneity of
HER2/NEU
gene amplification in endometrial serous carcinoma
. Genes, Chromosomes and Cancer 52:12, pages 1178-1186.
Crossref
Crossref
Juliana Benito, Zhihong Zeng, Marina KonoplevaWilliam R Wilson. (2013) Targeting hypoxia in the leukemia microenvironment. International Journal of Hematologic Oncology 2:4, pages 279-288.
Crossref
Crossref
S Attarha, S Andersson, M Mints & S Souchelnytskyi. (2013) Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers. British Journal of Cancer 109:3, pages 704-713.
Crossref
Crossref
Claudia Desiderio, Claudia Martelli, Diana Valeria Rossetti, Concezio Di Rocco, Luca D’Angelo, Massimo Caldarelli, Gianpiero Tamburrini, Federica Iavarone, Massimo Castagnola, Irene Messana, Tiziana Cabras & Gavino Faa. (2013) Identification of thymosins β4 and β10 in paediatric craniopharyngioma cystic fluid. Child's Nervous System 29:6, pages 951-960.
Crossref
Crossref
R. Kimmig, B. Aktas & M. Heubner. (2013) Endometriumkarzinom – operative Strategie und AdjuvanzEndometrial cancer – operative strategy and adjuvant treatment. Der Gynäkologe 46:5, pages 339-344.
Crossref
Crossref